Vascular access site complication in transfemoral coronary angiography between uninterrupted warfarin and heparin bridging.
Wanwarang WongcharoenKittipong PinyosamosornSiriluck GunaparnSuchada BoonnayhunTasalak ThonghongPannipa SuwannasomArintaya PhrommintikulPublished in: Journal of interventional cardiology (2017)
We demonstrated that an uninterrupted warfarin strategy did not increase vascular access site complications in patients undergoing transfemoral CAG compared to heparin bridging therapy. Due to the safety and the ease of uninterrupted warfarin strategy, this approach should be encouraged in patients receiving long-term warfarin who undergo elective transfemoral CAG.
Keyphrases
- direct oral anticoagulants
- venous thromboembolism
- atrial fibrillation
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- patients undergoing
- catheter ablation
- aortic valve replacement
- oral anticoagulants
- aortic valve
- growth factor
- risk factors
- stem cells
- heart failure
- mesenchymal stem cells
- bone marrow
- smoking cessation